These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3959033)

  • 21. Biochemistry and pharmacology of 7alpha-substituted androstenediones as aromatase inhibitors.
    Brueggemeier RW; O'Reilly JM; Lovely CJ; Ward PJ; Quinn AL; Baker D; Darby MV; Gu XJ; Gilbert NE
    J Steroid Biochem Mol Biol; 1997 Apr; 61(3-6):247-54. PubMed ID: 9365197
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aromatase inhibition in JAr choriocarcinoma cells by 7alpha-arylaliphatic androgens.
    Brueggemeier RW; Gilbert NE; Gu X; O'Reilly JM; Lovely CJ
    J Steroid Biochem Mol Biol; 1997 Apr; 61(1-2):73-7. PubMed ID: 9328212
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of the aromatase inhibitor 7 alpha-(4'-amino)phenylthio-4-androstene-3,17-dione in MCF-7 human mammary carcinoma cell culture.
    Brueggemeier RW; Katlic NE
    Cancer Res; 1987 Sep; 47(17):4548-51. PubMed ID: 3621153
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Development of aromatase inhibitors and analysis of their inhibitory activities].
    Numazawa M
    Yakugaku Zasshi; 1998 Dec; 118(12):539-53. PubMed ID: 9921263
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of 6,7-aziridinyl steroids and related compounds as inhibitors of aromatase (P-450arom).
    Njar VC; Grün G; Hartmann RW
    J Enzyme Inhib; 1995; 9(3):195-202. PubMed ID: 8847599
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inactivation of aromatase in vitro by 4-hydroxy-4-androstene-3,17-dione and 4-acetoxy-4-androstene-3,17-dione and sustained effects in vivo.
    Brodie AM; Garrett WM; Hendrickson JR; Tsai-Morris CH; Marcotte PA; Robinson CH
    Steroids; 1981 Dec; 38(6):693-702. PubMed ID: 7336466
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interactions of thiol-containing androgens with human placental aromatase.
    Bednarski PJ; Nelson SD
    J Med Chem; 1989 Jan; 32(1):203-13. PubMed ID: 2909733
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 7-substituted steroidal aromatase inhibitors: structure-activity relationships and molecular modeling.
    Li PK; Brueggemeier RW
    J Enzyme Inhib; 1990; 4(2):113-20. PubMed ID: 2098517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and structure-activity relationships of 6-substituted androst-4-ene analogs as aromatase inhibitors.
    Numazawa M; Kamiyama T; Tachibana M; Oshibe M
    J Med Chem; 1996 May; 39(11):2245-52. PubMed ID: 8667367
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and properties of the epimeric 6-hydroperoxyandrostenediones, new substrates/inhibitors of human placental aromatase.
    Tan L; Hrycay EG; Matsumoto K
    J Steroid Biochem; 1983 Sep; 19(3):1329-38. PubMed ID: 6621039
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Covalent modification of aromatase by a radiolabeled irreversible inhibitor.
    Snider CE; Brueggemeier RW
    J Steroid Biochem; 1985 Mar; 22(3):325-30. PubMed ID: 3990283
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Competitive inhibition and suicide inactivation of human placental aromatase by androst-4-ene-3,6-dione derivatives and 3 alpha-methoxyandrost-4-ene-6,17-dione.
    Numazawa M; Mutsumi A; Kigawa H
    Chem Pharm Bull (Tokyo); 1990 Nov; 38(11):3076-80. PubMed ID: 2085891
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 7-substituted 1,4,6-androstatriene-3,17-diones as enzyme-activated irreversible inhibitors of aromatase.
    Li PK; Brueggemeier RW
    J Steroid Biochem; 1990 Aug; 36(6):533-9. PubMed ID: 2214770
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition and inactivation of equine aromatase by steroidal and non-steroidal compounds. A comparison with human aromatase inhibition.
    Moslemi S; Seralini GE
    J Enzyme Inhib; 1997 Dec; 12(4):241-54. PubMed ID: 9502046
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and biochemical studies of 7-substituted 4,6-androstadiene-3,17-diones as aromatase inhibitors.
    Li PK; Brueggemeier RW
    J Med Chem; 1990 Jan; 33(1):101-5. PubMed ID: 2296006
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A new hypothesis based on suicide substrate inhibitor studies for the mechanism of action of aromatase.
    Covey DF; Hood WF
    Cancer Res; 1982 Aug; 42(8 Suppl):3327s-3333s. PubMed ID: 7083195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structure-activity relationships of 2alpha-substituted androstenedione analogs as aromatase inhibitors and their aromatization reactions.
    Numazawa M; Handa W; Hasegawa C; Takahashi M
    J Steroid Biochem Mol Biol; 2005 Dec; 97(4):353-9. PubMed ID: 16209922
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A- or B-ring-substituted derivatives of androst-4-ene-3,6,17-trione as aromatase inhibitors. Structure-activity relationships.
    Numazawa M; Tachibana M
    Steroids; 1994 Oct; 59(10):579-85. PubMed ID: 7878685
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stereochemistry of the functional group determines the mechanism of aromatase inhibition by 6-bromoandrostenedione.
    Osawa Y; Osawa Y; Coon MJ
    Endocrinology; 1987 Sep; 121(3):1010-6. PubMed ID: 3622372
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 7 alpha-substituted androstenediones as effective in vitro and in vivo inhibitors of aromatase.
    Brueggemeier RW; Li PK; Snider CE; Darby MV; Katlic NE
    Steroids; 1987; 50(1-3):163-78. PubMed ID: 3504058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.